Intranasal composition of methylcobalamin
US11331334B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2018 |
| Grant date | May 17, 2022 |
| Priority date | — |
| Expiry date | Mar 7, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an intranasal composition, particularly once weekly intranasal composition comprising methylcobalamin and at least one gelling agent and a process for preparation thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.